4.6 Article

Short-form Zarit Caregiver Burden Interviews were valid in advanced conditions

Journal

JOURNAL OF CLINICAL EPIDEMIOLOGY
Volume 63, Issue 5, Pages 535-542

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jclinepi.2009.06.014

Keywords

Carer; Outcome; Palliative; Burden; Aging; Validity

Funding

  1. NHS Executive (London and South East)
  2. Department of Health [030/0066]
  3. Department of Health, Policy Research Programme
  4. National Cancer Research Institute, UK,

Ask authors/readers for more resources

Objectives: To assess six short-form versions of Zarit Burden Interview (ZBI-12, ZBI-8, ZBI-7, ZBI-6, ZBI-4, and ZBI-1) among three caregiving populations. Study Design and Setting: Secondary analysis of carers' surveys in advanced cancer (n = 105), dementia (n = 131), and acquired brain injury (n = 215). All completed demographic information and the ZBI-22 were used. Validity was assessed by Spearman correlations and internal consistency using Cronbach's alpha. Overall discrimination ability was evaluated using the area under the receiver operating characteristic curve (AUC). Results: All short-form versions, except the ZBI-1 in advanced cancer (rho = 0.63), displayed good correlations (rho = 0.74-0.97) with the ZBI-22. Cronbach's alphas suggested high internal consistency (range: 0.69-0.89) even for the ZBI-4. Discriminative ability was good for all short forms (AUC range: 0.90-0.99); the best AUC was for ZBI-12 (0.99; 95% confidence interval [CIF 0.98-0.99) and the second best for ZBI-7 (0.98; 95% Cl: 0.96-0.98) and ZBI-6 (0.98; 95% Cl: 0.97-0.99). Conclusions: All six short-form ZBI have very good validity, internal consistency, and discriminative ability. ZBI-12 is endorsed as the best short-form version; ZBI-7 and ZBI-6 show almost equal properties and are suitable when a fewer-question version is needed. ZBI-4 and ZBI-1 are suitable for screening, but ZBI-1 may be less valid in cancer. (C) 2010 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available